CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands | Total | Cumulative Effect Period of Adoption, Adjustment | Cumulative Effect Period of Adoption, Adjusted Balance | Common Stock | Common StockCumulative Effect Period of Adoption, Adjusted Balance | Retained Earnings | Retained EarningsCumulative Effect Period of Adoption, Adjustment | Retained EarningsCumulative Effect Period of Adoption, Adjusted Balance | Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive LossCumulative Effect Period of Adoption, Adjusted Balance |
Beginning balance at Dec. 28, 2019 | $ 197,751 | | $ 197,548 | $ 9,265 | $ 9,265 | $ 200,249 | | $ 200,046 | $ (11,763) | $ (11,763) |
Beginning balance (ASC 326) at Dec. 28, 2019 | | $ (203) | | | | | $ (203) | | | |
Beginning balance (in shares) at Dec. 28, 2019 | | | | 7,814,797 | 7,814,797 | | | | | |
Increase (Decrease) in Shareholders' Equity | | | | | | | | | | |
Net income | 6,468 | | | | | 6,468 | | | | |
Foreign currency translation adjustment | (2,427) | | | | | | | | (2,427) | |
Issuance of restricted common stock for contingent consideration | 0 | | | | | | | | | |
Exercise of stock options | 151 | | | $ 151 | | | | | | |
Exercise of stock options (in shares) | | | | 8,200 | | | | | | |
Share-based compensation expense | $ 655 | | | $ 655 | | | | | | |
Restricted shares vesting (in shares) | 23,884 | | | | | | | | | |
Redemption of vested employee restricted shares for tax withholding | $ (390) | | | $ (390) | | | | | | |
Redemption of vested employee restricted shares for tax withholding (in shares) | | | | (7,843) | | | | | | |
Shares repurchased | (3,810) | | | $ (3,810) | | | | | | |
Shares repurchased (in shares) | | | | (82,613) | | | | | | |
Accrued dividends on unvested shares | 1 | | | | | 1 | | | | |
Cash paid on dividend equivalents | (40) | | | | | (40) | | | | |
Cash dividends paid to shareholders (per share) | (1,796) | | | | | (1,796) | | | | |
Ending balance at Mar. 28, 2020 | 196,360 | | | $ 5,871 | | 204,679 | | | (14,190) | |
Ending balance (in shares) at Mar. 28, 2020 | | | | 7,756,425 | | | | | | |
Beginning balance at Jan. 02, 2021 | $ 209,019 | | | $ 503 | | 216,999 | | | (8,483) | |
Beginning balance (in shares) at Jan. 02, 2021 | 7,693,497 | | | 7,693,497 | | | | | | |
Increase (Decrease) in Shareholders' Equity | | | | | | | | | | |
Net income | $ 10,501 | | | | | 10,501 | | | | |
Foreign currency translation adjustment | (111) | | | | | | | | (111) | |
Issuance of restricted common stock for contingent consideration | $ 2,250 | | | | | | | | | |
Issuance of restricted common stock for contingent consideration (in shares) | 40,039 | | | | | | | | | |
Exercise of stock options | $ 1,113 | | | $ 1,113 | | | | | | |
Exercise of stock options (in shares) | | | | 41,008 | | | | | | |
Share-based compensation expense | 842 | | | $ 842 | | | | | | |
Restricted shares vesting (in shares) | | | | 29,494 | | | | | | |
Redemption of vested employee restricted shares for tax withholding | (588) | | | $ (588) | | | | | | |
Redemption of vested employee restricted shares for tax withholding (in shares) | | | | (9,895) | | | | | | |
Shares repurchased | (9,642) | | | $ (4,120) | | (5,522) | | | | |
Shares repurchased (in shares) | | | | (166,552) | | | | | | |
Accrued dividends on unvested shares | 5 | | | | | 5 | | | | |
Cash paid on dividend equivalents | (79) | | | | | (79) | | | | |
Cash dividends paid to shareholders (per share) | (1,982) | | | | | (1,982) | | | | |
Ending balance at Apr. 03, 2021 | $ 211,328 | | | $ 0 | | $ 219,922 | | | $ (8,594) | |
Ending balance (in shares) at Apr. 03, 2021 | 7,627,591 | | | 7,627,591 | | | | | | |